The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 4, 2026 | Pescovitz Ora H. | Director | Grant(A) | 13K | — | $0 |
| Jun 4, 2026 | Heron Patrick J | Director, 10% Owner | Grant(A) | 13K | — | $0 |
| Jun 4, 2026 | Stelzer Laurie | Director | Grant(A) | 13K | — | $0 |
| Jun 4, 2026 | Hoerter Steven L. | Director | Grant(A) | 13K | — | $0 |
| Jun 4, 2026 | Ryder Steven | Director | Grant(A) | 13K | — | $0 |
| Jun 4, 2026 | Aynechi Tiba | Director | Grant(A) | 13K | — | $0 |
| Jun 4, 2026 | Mathers Edward T | Director | Grant(A) | 13K | — | $0 |
| May 8, 2026 | Azoulay Salomon | Chief Medical Officer | Option exercise(M) | 55K | $10.46 | $575K |
| May 8, 2026 | Azoulay Salomon | Chief Medical Officer | Sell(S) | 55K | $38.38 | $2.1M |
| May 8, 2026 | Azoulay Salomon | Chief Medical Officer | Option exercise(M) | 15K | $16.00 | $240K |
| May 8, 2026 | Azoulay Salomon | Chief Medical Officer | Sell(S) | 15K | $38.30 | $575K |
| May 8, 2026 | Azoulay Salomon | Chief Medical Officer | Option exercise(M) | 55K | — | $0 |
| May 8, 2026 | Azoulay Salomon | Chief Medical Officer | Option exercise(M) | 15K | — | $0 |
| May 6, 2026 | Azoulay Salomon | Chief Medical Officer | Sell(S) | 231 | $29.54 | $7K |
| May 6, 2026 | Hawryluk P. Kent | President & CEO, Director | Sell(S) | 607 | $29.54 | $18K |
| May 1, 2026 | Hoerter Steven L. | Director | Grant(A) | 12K | — | $0 |
| May 1, 2026 | Hoerter Steven L. | Director | Grant(A) | 74K | — | $0 |
| Mar 13, 2026 | Hawryluk P. Kent | President & CEO, Director | Buy(P) | 19K | $28.41 | $526K |
| Feb 26, 2026 | Hawryluk P. Kent | President & CEO, Director | Option exercise(M) | 29K | $16.00 | $460K |
| Feb 26, 2026 | Hawryluk P. Kent | President & CEO, Director | Option exercise(M) | 29K | — | $0 |
| Feb 2, 2026 | Hawryluk P. Kent | President & CEO, Director | Grant(A) | 35K | — | $0 |
| Feb 2, 2026 | Hawryluk P. Kent | President & CEO, Director | Grant(A) | 165K | — | $0 |
| Feb 2, 2026 | Bartram Richard | Chief Financial Officer | Grant(A) | 15K | — | $0 |
| Feb 2, 2026 | Bartram Richard | Chief Financial Officer | Grant(A) | 70K | — | $0 |
| Feb 2, 2026 | Azoulay Salomon | Chief Medical Officer | Grant(A) | 15K | — | $0 |
| Feb 2, 2026 | Azoulay Salomon | Chief Medical Officer | Grant(A) | 70K | — | $0 |
| Jan 20, 2026 | Stelzer Laurie | Director | Grant(A) | 32K | — | $0 |
| Nov 22, 2025 | Hoerter Steven L. | Director | Grant(A) | 0 | — | $0 |
| Nov 6, 2025 | Hoerter Steven L. | Director | Grant(A) | 34K | — | $0 |
| Oct 24, 2025 | Hawryluk P. Kent | President & CEO, Director | Option exercise(M) | 183K | $3.25 | $594K |
| Oct 24, 2025 | Hawryluk P. Kent | President & CEO, Director | Option exercise(M) | 183K | — | $0 |
| Oct 20, 2025 | Hawryluk P. Kent | President & CEO, Director | Buy(P) | 20K | $13.64 | $273K |
| Oct 17, 2025 | Hoerter Steven L. | Director | Buy(P) | 20K | $13.25 | $265K |
| Sep 26, 2025 | FHMLS X, L.P. | 10% Owner | Buy(P) | 667K | $18.00 | $12.0M |
| Jun 5, 2025 | Pescovitz Ora H. | Director | Grant(A) | 16K | — | $0 |
| Jun 5, 2025 | Heron Patrick J | Director, 10% Owner | Grant(A) | 16K | — | $0 |
| Jun 5, 2025 | Ryder Steven | Director | Grant(A) | 16K | — | $0 |
| Jun 5, 2025 | Cornelius James M | Director | Grant(A) | 16K | — | $0 |
| Jun 5, 2025 | Aynechi Tiba | Director | Grant(A) | 16K | — | $0 |
| Jun 5, 2025 | Hoerter Steven L. | Director | Grant(A) | 16K | — | $0 |
| Jun 5, 2025 | Mathers Edward T | Director, 10% Owner | Grant(A) | 16K | — | $0 |
| Apr 8, 2025 | Pescovitz Ora H. | Director | Buy(P) | 8K | $5.89 | $45K |
| Apr 7, 2025 | Hoerter Steven L. | Director | Grant(A) | 32K | — | $0 |
| Feb 18, 2025 | OrbiMed Genesis GP LLC | Director, 10% Owner | Buy(P) | 94K | $10.84 | $1.0M |
| Feb 18, 2025 | OrbiMed Genesis GP LLC | Director, 10% Owner | Buy(P) | 49K | $10.84 | $532K |
| Feb 18, 2025 | Gordon Carl L | Director, 10% Owner | Buy(P) | 49K | $10.84 | $532K |
| Feb 18, 2025 | Gordon Carl L | Director, 10% Owner | Buy(P) | 94K | $10.84 | $1.0M |
| Feb 14, 2025 | OrbiMed Genesis GP LLC | Director, 10% Owner | Buy(P) | 18K | $9.90 | $178K |
| Feb 14, 2025 | OrbiMed Genesis GP LLC | Director, 10% Owner | Buy(P) | 30K | $9.85 | $291K |
| Feb 14, 2025 | Gordon Carl L | Director, 10% Owner | Buy(P) | 30K | $9.85 | $291K |
| Feb 14, 2025 | Gordon Carl L | Director, 10% Owner | Buy(P) | 18K | $9.90 | $178K |
| Feb 4, 2025 | Hawryluk P. Kent | President & CEO, Director | Buy(P) | 50K | $10.69 | $535K |
| Feb 3, 2025 | Hawryluk P. Kent | President & CEO, Director | Grant(A) | 243K | — | $0 |
| Feb 3, 2025 | Bartram Richard | Chief Financial Officer | Grant(A) | 95K | — | $0 |
| Feb 3, 2025 | Azoulay Salomon | Chief Medical Officer | Grant(A) | 90K | — | $0 |
| Sep 16, 2024 | Yang Rick | 10% Owner | Conversion(C) | 12.3M | — | — |
| Sep 16, 2024 | Aynechi Tiba | Director | Conversion(C) | 16.7M | — | — |
| Sep 16, 2024 | Yang Rick | 10% Owner | Conversion(C) | 25.1M | — | — |
| Sep 16, 2024 | Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | 10% Owner | Conversion(C) | 1.4M | — | — |
| Sep 16, 2024 | Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | 10% Owner | Conversion(C) | 404K | — | — |
| Sep 16, 2024 | Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | 10% Owner | Conversion(C) | 4.9M | — | $0 |
| Sep 16, 2024 | Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | 10% Owner | Conversion(C) | 16.7M | — | $0 |
| Sep 16, 2024 | Gordon Carl L | Director, 10% Owner | Buy(P) | 500K | $16.00 | $8.0M |
| Sep 16, 2024 | Gordon Carl L | Director, 10% Owner | Buy(P) | 250K | $16.00 | $4.0M |
| Sep 16, 2024 | Gordon Carl L | Director, 10% Owner | Conversion(C) | 2.7M | — | — |
| Sep 16, 2024 | Gordon Carl L | Director, 10% Owner | Conversion(C) | 404K | — | — |
| Sep 16, 2024 | Gordon Carl L | Director, 10% Owner | Conversion(C) | 19.6M | — | — |
| Sep 16, 2024 | Gordon Carl L | Director, 10% Owner | Conversion(C) | 4.9M | — | — |
| Sep 16, 2024 | Gordon Carl L | Director, 10% Owner | Conversion(C) | 12.4M | — | — |
| Sep 16, 2024 | Aynechi Tiba | Director | Buy(P) | 750K | $16.00 | $12.0M |
| Sep 16, 2024 | Aynechi Tiba | Director | Conversion(C) | 1.4M | — | — |
| Sep 16, 2024 | Hawryluk P. Kent | President & CEO, Director | Conversion(C) | 284K | — | — |
| Sep 16, 2024 | Hawryluk P. Kent | President & CEO, Director | Conversion(C) | 116K | — | — |
| Sep 16, 2024 | Hawryluk P. Kent | President & CEO, Director | Conversion(C) | 2.0M | — | — |
| Sep 16, 2024 | Hawryluk P. Kent | President & CEO, Director | Conversion(C) | 346K | — | — |
| Sep 16, 2024 | Hawryluk P. Kent | President & CEO, Director | Conversion(C) | 971K | — | — |
| Sep 16, 2024 | Hawryluk P. Kent | President & CEO, Director | Conversion(C) | 77K | — | — |
| Sep 16, 2024 | Hawryluk P. Kent | President & CEO, Director | Conversion(C) | 1.4M | — | — |
| Sep 16, 2024 | Heron Patrick J | Director, 10% Owner | Buy(P) | 625K | $16.00 | $10.0M |
| Sep 16, 2024 | Heron Patrick J | Director, 10% Owner | Conversion(C) | 3.9M | — | — |
| Sep 16, 2024 | Heron Patrick J | Director, 10% Owner | Conversion(C) | 28.3M | — | — |
| Sep 16, 2024 | Heron Patrick J | Director, 10% Owner | Conversion(C) | 18.9M | — | — |
| Sep 16, 2024 | Cornelius James M | Director | Conversion(C) | 102K | — | — |
| Sep 16, 2024 | Cornelius James M | Director | Conversion(C) | 233K | — | — |
| Sep 16, 2024 | Cornelius James M | Director | Conversion(C) | 994K | — | — |
| Sep 16, 2024 | FHMLS X, L.P. | 10% Owner | Conversion(C) | 3.9M | — | — |
| Sep 16, 2024 | FHMLS X, L.P. | 10% Owner | Buy(P) | 625K | $16.00 | $10.0M |
| Sep 16, 2024 | FHMLS X, L.P. | 10% Owner | Conversion(C) | 28.3M | — | — |
| Sep 16, 2024 | FHMLS X, L.P. | 10% Owner | Conversion(C) | 18.9M | — | — |
| Sep 16, 2024 | NEA Partners 17, L.P. | 10% Owner | Buy(P) | 500K | $16.00 | $8.0M |
| Sep 16, 2024 | NEA Partners 17, L.P. | 10% Owner | Conversion(C) | 2.1M | — | — |
| Sep 16, 2024 | NEA Partners 17, L.P. | 10% Owner | Conversion(C) | 1.0M | — | — |
| Sep 16, 2024 | NEA Partners 17, L.P. | 10% Owner | Conversion(C) | 12.3M | — | — |
| Sep 16, 2024 | NEA Partners 17, L.P. | 10% Owner | Conversion(C) | 25.1M | — | — |
| Sep 16, 2024 | Orbimed Advisors LLC | Director, 10% Owner | Conversion(C) | 2.7M | — | — |
| Sep 16, 2024 | Orbimed Advisors LLC | Director, 10% Owner | Buy(P) | 500K | $16.00 | $8.0M |
| Sep 16, 2024 | Orbimed Advisors LLC | Director, 10% Owner | Conversion(C) | 404K | — | — |
| Sep 16, 2024 | Orbimed Advisors LLC | Director, 10% Owner | Buy(P) | 250K | $16.00 | $4.0M |
| Sep 16, 2024 | Orbimed Advisors LLC | Director, 10% Owner | Conversion(C) | 12.4M | — | — |
| Sep 16, 2024 | Orbimed Advisors LLC | Director, 10% Owner | Conversion(C) | 19.6M | — | — |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-01-04 → 2026-07-20. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).